Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTDverified

300534.SZ

Price:

$9.98

Market Cap:

$3.03B

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines, health food, and APIs. It offers Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, and Astragalus Angelica capsules, as well as berberine tannin films. The company also engages in the planting, acquisition, processing, sales, and commercial distribution of Chinese medicinal materials; investment and ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-09-13

Stock Exchange

SHZ

Ticker

300534.SZ

The PE Ratio as of December 2025 (TTM) for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) is 110.89

According to Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD’s latest financial reports and current stock price. The company's current PE Ratio is 110.89. This represents a change of 594.62% compared to the average of 15.96 of the last 4 quarters.

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) Historical PE Ratio (quarterly & annually)

How has 300534.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD over the last ten years is 127.46. The current 110.89 PE Ratio has changed 8.60% with respect to the historical average. Over the past ten years (40 quarters), 300534.SZ's PE Ratio was at its highest in in the June 2021 quarter at 5.10K. The PE Ratio was at its lowest in in the September 2018 quarter at -13448.68.

Quarterly (TTM)
Annual

Average

127.46

Median

103.21

Minimum

-490.35

Maximum

959.17

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 579.03%

Maximum Annual PE Ratio = 959.17

Minimum Annual Increase = -151.12%

Minimum Annual PE Ratio = -490.35

Quarterly (TTM)
Annual
YearPE RatioChange
2024102.23110.47%
202348.57-53.38%
2022104.18-121.25%
2021-490.35-151.12%
2020959.17579.03%
2019141.26-1.02%
2018142.72-19.57%
2017177.45142.63%
201673.14351.53%
201516.20-0.42%

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) Average PE Ratio

How has 300534.SZ PE Ratio performed in the past?

The current PE Ratio of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

85.00

5-year avg

144.76

10-year avg

127.46

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) PE Ratio vs. Peers

How is 300534.SZ’s PE Ratio compared to its peers?

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD’s PE Ratio is greater than Anhui Fengyuan Pharmaceutical Co., Ltd. (26.75), greater than Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (-44.32), greater than Ginwa Enterprise (Group) Inc. (36.25), greater than Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (24.40), greater than Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (27.99), greater than Hunan Hansen Pharmaceutical Co., Ltd. (19.98), greater than Guizhou Yibai Pharmaceutical Co., Ltd. (-14.48), greater than Baotou Dongbao Bio-Tech Co.,Ltd (46.53), less than ShanXi C&Y Pharmaceutical Group Co., Ltd. (122.35), greater than Tus-Pharmaceutical Group Co., Ltd. (-23.70),

Build a custom stock screener for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD's PE Ratio?

How is the PE Ratio calculated for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)?

What is the highest PE Ratio for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)?

What is the 3-year average PE Ratio for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)?

What is the 5-year average PE Ratio for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)?

How does the current PE Ratio for Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) compare to its historical average?